Atossa Therapeutics Inc (ATOS) is lower by Wednesday morning, with the stock falling -1.20% in pre-market trading to 2.47. ATOS's short-term technical score of 46 indicates that the stock has traded less bullishly over the last month than 54% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, Atossa Therapeutics Inc ranks higher than 79% of stocks. Atossa Therapeutics Inc has fallen 12.59% over the past month, closing at $2.91 on October 20. During this period of time, the stock fell as low as $2.50 and as high as $2.98. ATOS has an average analyst recommendation of Strong Buy. The company has an average price target of $7.00.
Atossa Therapeutics Inc has a Long-Term Technical rank of 21. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 79% of the market scoring higher. In the Biotechnology industry which is number 139 by this metric, ATOS ranks better than 48% of stocks.
Should You Sell Atossa Therapeutics Inc (ATOS) Stock Wednesday Morning?
ATOS has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on ATOS!